✦ LIBER ✦

Treatment of Patients with Advanced Lung Cancer and Poor Performance Status

✍ Scribed by Rogerio C. Lilenbaum

Book ID: 119935515
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 93 KB
Volume: 6
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2004.s.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-Agent Epidermal Growth Factor Rec

Single-Agent Epidermal Growth Factor Receptor Inhibitor Gefitinib for the Treatment of Patients with Advanced Non—Small-Cell Lung Cancer and Poor Performance Status

✍ Nagla Abdel Karim; Salma Musaad; Abdul Rahman Jazieh 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Combination Treatment with Weekly Doceta

Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial

✍ John D. Hainsworth; Joan B. Erland; John H. Barton; Dana S. Thompson; M. Patrick 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

Sequential versus concurrent paclitaxel

Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials

✍ Marsland, T.A.; Garfield, D.H.; Khan, M.M.; Look, R.M.; Boehm, K.A.; Asmar, L. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Weekly docetaxel versus docetaxel/gemcit

Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer : A randomized phase 3 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; David R. Spigel; Cindy Farley; Dianna L. Shipley; James D. B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

## Abstract ## BACKGROUND. The aim of this study was to compare the efficacy of single‐agent weekly docetaxel with the combination of docetaxel and gemcitabine in elderly and/or poor performance status patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Previously untreated pat

The safety and efficacy of EGFR TKIs mon

The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status

✍ Liu, Shan; Wang, Deqiang; Chen, Bo; Wang, Yan; Zhao, Weihong; Wu, Jianqing 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Treatment approaches in patients with ad

Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status

✍ Ramaswamy Govindan; David H. Garfield 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB